For PainWeekEnd Webinar Attendees on 5/16/20; Prepared by Jen Bolen, JD DEA Link DEA Diversion https://www.deadiversion.usdoj.gov/coronavirus.html DEA Diversion https://www.deadiversion.usdoj.gov/covid-19/coronavirus_state.htm. FSMB Link https://www.fsmb.org/siteassets/advocacy/pdf/states-waiving-licensure-requirements-for- FSMB telehealth-in-response-to-covid-19.pdf. Pharmacy National Link National Alliance of https://naspa.us/resource/covid-19-information-from-the-states/. A State Pharmacy Assoc. State Link Alabama https://www.albme.org/tele.html Arizona https://www.azmd.gov/Misc/MiscInfo/COVID-19; https://azpharmacy.org/4266-2/. https://www.mbc.ca.gov/Licensees/prescribing/; California https://www.pharmacy.ca.gov/licensees/covid19_faq.shtml. https://www.colorado.gov/pacific/sites/default/files/COVID- Colorado 19%20Guidance%20for%20Prescribers%2003-20-2020.pdf. Delaware https://dpr.delaware.gov/boards/controlledsubstances/; https://dpr.delaware.gov/infoguide/. http://www.flhealthsource.gov/FloridaTakeControl/; https://flboardofmedicine.gov/latest- Florida news/take-control-of-controlled-substances/. https://gbp.georgia.gov/press-releases/2020-04-08/covid-19-coronavirus-response-georgia-board- pharmacy; Georgia https://gdna.georgia.gov/; https://www.mag.org/georgia/Public/News/News_Articles/GCMB_passes_emergency_prescribing_ru le.aspx. https://www.iowamedical.org/iowa/Iowa_Public/Public_Affairs/News/2019/COVID- 19%20Resource%20Page.aspx; Iowa https://pharmacy.iowa.gov/sites/default/files/documents/2020/04/faqs_covid-19_040120.pdf; https://medicalboard.iowa.gov/ Illinois https://www.idfpr.com/profs/ContSub.asp. https://www.coronavirus.in.gov/; Indiana https://www.in.gov/pla/medical.htm https://pharmacy.ky.gov/Pages/COVID-19-Information.aspx https://pharmacy.ky.gov/Documents/APPLICABLE%20KENTUCKY%20CONTROLLED%20SUBSTANCES% 20LAWS%204.2.2020%20V%201.pdf Kentucky https://kbml.ky.gov/Pages/index.aspx. https://kbml.ky.gov/Documents/Advisory%20on%20Prescribing%20During%20Declaration%20of%20 Emergency.pdf https://www.lammico.com/article/LSBME-board-changes. Louisiana https://www.lsbme.la.gov/content/covid-19-crisis-information. https://health.maryland.gov/OCSA/Pages/home.ASPX Maryland https://health.maryland.gov/ocsa/Documents/Controlled%20Dangerous%20Substances%20(CDS)%20 Frequently%20Asked%20Questions%20during%20COVID-19.pdf. https://www.michiganpharmacists.org/COVID-19; https://www.michiganpa.org/page/54/FAQ-Controlled-Substances-Answers.htm https://www.michigan.gov/whitmer/0,9309,7-387-90499_90705-523301--,00.html; Michigan https://www.mafp.com/news/controlled-substance-administrative-rule-changes-in-effect-as-of-jan-4; https://www.michigan.gov/lara/0,4601,7-154-89334_72600_72603_27529_27541---,00.html#block- 3_106847 https://mn.gov/boards/pharmacy/resourcesfaqs/faqs/generalfaqs.jsp Minnesota https://mn.gov/boards/medical-practice/ https://health.mo.gov/safety/bndd/; Missouri https://pr.mo.gov/pharmacists-publications-resources.asp; https://www.msma.org/guide-to-controlled-substances.html http://boards.bsd.dli.mt.gov/med; Montana
https://www.nj.gov/governor/news/news/562020/20200401b.shtml https://www.cchpca.org/telehealth-policy/current-state-laws-and-reimbursement-policies/new- New Jersey jersey-professional-regulationhealth-safety-online-prescribing; https://www.njconsumeraffairs.gov/COVID19/ https://www.health.ny.gov/professionals/narcotic/laws_and_regulations/; New York https://www1.nyc.gov/assets/doh/downloads/pdf/imm/prescribing-opioid-guidance.pdf; https://health.ny.gov/health_care/medicaid/covid19/2020-03-19_guide_med_pharm.htm. https://bop.nv.gov/resources/ALL/COVID-19_Information/ Nevada https://nvdoctors.org/practice-resources/prescribing-opioids/ https://nvdoctors.org/coronavirus-resource-center/ https://www.ncmedboard.org/resources-information/professional-resources/publications/forum- newsletter/notice/use-of-telemedicine-amid-covid-19-concerns; North Carolina https://www.ncmedboard.org/resources-information/professional-resources/publications/forum- newsletter/notice/use-of-telemedicine-amid-covid-19-concerns https://www.pharmacy.ohio.gov/Pubs/Special.aspx https://www.pharmacy.ohio.gov/FAQ/Prescribers.aspx; Ohio https://coronavirus.ohio.gov/wps/portal/gov/covid-19/healthcare-providers-and-local-health- districts/ https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Medicine/Pages/default.aspx https://www.health.pa.gov/topics/programs/Pages/Electronic%20Prescribing.aspx Pennsylvania https://www.health.pa.gov/topics/programs/Electronic%20Prescribing/Pages/Prescribers.aspx https://www.pamedsoc.org/detail/article/electronic-prescribing-law https://www.papharmacists.com/page/PennsylvaniaLaws https://health.ri.gov/healthcare/medicine/about/controlledsubstances/ https://octariusrx.com/new-rhode-island-regulations-on-electronic-prescribing-of-controlled- substances/ Rhode Island https://health.ri.gov/publications/policies/RIDOH-Policies-Telemedicine.BMLD.3.20.20.pdf https://rules.sos.ri.gov/regulations/index/active?search=&keywords=opioid&agencies=216&sortby=r elevance&order=desc https://www.tnpharm.org/news/news-posts-pages/governor-lee-issues-new-executive-order-to- combat-covid-19/ https://www.vumc.org/nursingoap/52569 Tennessee https://www.tn.gov/health/health-program-areas/health-professional-boards/me-board.html https://www.tn.gov/governor/covid-19.html https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html https://www.texmed.org/TexasMedicineDetail.aspx?id=53011 https://www.texmed.org/Telemedicine/ Texas (5/8/2020) https://www.texmed.org/Template.aspx?id=52892 https://www.texaspain.org/index.php?option=com_dailyplanetblog&tag=opioids https://www.pharmacy.texas.gov/coronavirus/ http://www.pswi.org/Resources/COVID-19-Information https://www.wismed.org/Wisconsin/wismed/News/medigram/2020-medigram/medigram-april-16- 2020.aspx?WebsiteKey=7406aa79-0073-47e6-a857-f501c7ccdd56&hkey=f2528e54-8239-4ebb-b051- Wisconsin 8b5e77add83e https://dsps.wi.gov/pages/BoardsCouncils/Pharmacy/Default.aspx https://dsps.wi.gov/pages/Home.aspx
Filename: For PainWeekEnd Webinar Attendees on 5.docx Directory: /Users/BOLEN2013/Library/Containers/com.microsoft.Word/Data /Documents Template: /Users/BOLEN2013/Library/Group Containers/UBF8T346G9.Office/User Content.localized/Templates.localized/Normal.dotm Title: Subject: Author: Jennifer Bolen Keywords: Comments: Creation Date: 5/15/20 2:14:00 PM Change Number: 13 Last Saved On: 5/15/20 4:54:00 PM Last Saved By: Jennifer Bolen Total Editing Time: 42 Minutes Last Printed On: 5/15/20 4:55:00 PM As of Last Complete Printing Number of Pages: 2 Number of Words: 145 Number of Characters: 12,665 (approx.)
Recommend
More recommend